B7-H3 101: Understanding B7-H3 Expression in Solid Tumors, Including SCLC, Esophageal and Prostate Cancers, and NSCLC Squamous Cell and Its Association With Undesirable Treatment Outcomes and Survival Time

B7-H3 101: Understanding B7-H3 Expression in Solid Tumors, Including SCLC, Esophageal and Prostate Cancers, and NSCLC Squamous Cell and Its Association With Undesirable Treatment Outcomes and Survival Time

Are you familiar with B7-H3 and its role in the body? Challenge your skills and boost your confidence by exploring this emerging anti-cancer drug therapy target. Receive real-time feedback and curated resources based on your current level of knowledge. Your customized educational pathway, available for download upon activity completion, will feature education developed in collaboration with expert faculty on the B7 family, the effects of B7-H3 on immune pathways, the rationale for B7-H3 as a drug target, and a review of B7-H3 targeted agents currently under development.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/harnessing-power-artificial-intelligence-personalize-learning-pathways
  • Start Date: 2024-09-27 05:00:00
  • End Date: 2024-09-27 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.5 hours
    AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
    Pharmacy: 0.5 hours
  • Commercial Support: Source: Daiichi Sankyo, Inc. - Amount: 74750.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.